Published in Nutr Metab Cardiovasc Dis on October 01, 2004
Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes (2008) 1.42
Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement (2012) 1.28
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci (2010) 1.11
Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol (2013) 1.08
Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. Am J Physiol Heart Circ Physiol (2011) 1.02
No significant independent relationships with cardiometabolic biomarkers were detected in the Observation of Cardiovascular Risk Factors in Luxembourg study population. Nutr Res (2014) 0.96
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. J Neuroinflammation (2012) 0.91
Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes Metab Syndr Obes (2011) 0.90
Metabolic syndrome and obesity in an insect. Proc Natl Acad Sci U S A (2006) 0.89
Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats. Mol Med (2010) 0.89
Protectin DX, a double lipoxygenase product of DHA, inhibits both ROS production in human neutrophils and cyclooxygenase activities. Lipids (2013) 0.83
The role of obesity in gastrointestinal cancer: evidence and opinion. Therap Adv Gastroenterol (2014) 0.82
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget (2016) 0.81
Gender differences in fat distribution and inflammatory markers among Arabs. Mediators Inflamm (2013) 0.80
New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol (2016) 0.80
Non-alcoholic fatty liver disease and psoriasis: So far, so near. World J Hepatol (2015) 0.79
Association of IL-6 polymorphism -174G/C and metabolic syndrome in hypertensive patients. Biomed Res Int (2015) 0.76
Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases. J Immunol Res (2017) 0.75
Enhancing of women functional status with metabolic syndrome by cardioprotective and anti-inflammatory effects of combined aerobic and resistance training. PLoS One (2014) 0.75
Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatrics (1997) 15.08
Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg (2004) 2.31
Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol (1980) 2.22
The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia (2000) 1.86
Oxidative stress and insulin action: is there a relationship? Diabetologia (1996) 1.86
The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res (2005) 1.50
Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am J Clin Nutr (2001) 1.49
Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost (2004) 1.48
Association of body weight with sexual function in women. Int J Impot Res (2007) 1.43
Pregnancy as environmental factor precipitating IDDM. Diabetes Care (1989) 1.43
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA (1999) 1.42
Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost (1990) 1.40
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia (2002) 1.38
Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res (2010) 1.38
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis (2010) 1.36
Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation (2000) 1.27
Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest (2001) 1.23
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis (2011) 1.21
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med (2009) 1.18
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol (1998) 1.15
Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab (1991) 1.15
Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab (2011) 1.14
Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med (1990) 1.14
Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr (1993) 1.14
Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Obes Metab (2011) 1.14
Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet Med (2010) 1.13
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res (2005) 1.11
Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care (2000) 1.10
Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest (2004) 1.09
Impaired glucose metabolism in heroin and methadone users. Horm Metab Res (1987) 1.07
Acute hyperglycemia and autonomic function. Diabetes Care (2001) 1.07
Influence of acetylsalicylic acid on glucose turnover in normal man. Diabete Metab (1982) 1.06
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol (1995) 1.06
Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest (2013) 1.04
Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia (2001) 1.02
Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism (1994) 1.02
Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism (1983) 1.01
The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia (1978) 0.99
Effect of metformin on food intake in obese subjects. Eur J Clin Invest (1998) 0.99
Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia (1998) 0.98
High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia (2001) 0.98
Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol (1994) 0.98
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol (2001) 0.98
Resting metabolic rate and respiratory quotient in human longevity. J Clin Endocrinol Metab (2004) 0.97
Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care (1993) 0.96
Obesity and sexual dysfunction, male and female. Int J Impot Res (2008) 0.95
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med (1992) 0.95
Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res (2010) 0.94
Predictors of post-traumatic stress disorder following severe injury. Depress Anxiety (2001) 0.94
Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia (1986) 0.93
Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res (2006) 0.93
Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med (1991) 0.92
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia (1993) 0.91
Oxidative stress in the metabolic syndrome. J Endocrinol Invest (2006) 0.90
Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest (2002) 0.90
Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab (2011) 0.90
Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest (1999) 0.89
Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia (1988) 0.88
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia (1982) 0.87
Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials. Int J Clin Pract (2011) 0.87
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia (2004) 0.87
Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res (2006) 0.87
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism (1991) 0.87
Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia (1995) 0.87
Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care (1992) 0.87
Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther (2011) 0.87
Morphine, opioid peptides, and pancreatic islet function. Diabetes Care (1984) 0.86
Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res (2011) 0.86
Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab (2001) 0.86
Pharmacokinetic-pharmacodynamic relationships of Acarbose. Clin Pharmacokinet (1996) 0.86
GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Curr Med Res Opin (2011) 0.86
Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care (1996) 0.85
Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial. Diabetes Obes Metab (2011) 0.84
Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res (2007) 0.84
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) (1991) 0.84
Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies. Diabete Metab (1995) 0.84
Use of microphysiometry for analysis of heterologous ion channels expressed in yeast. Nat Biotechnol (1996) 0.83
Depressed antithrombin III biological activity in opiate addicts. J Clin Pathol (1984) 0.83
Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. J Clin Endocrinol Metab (1988) 0.82
Elevated post-prandial free fatty acids are associated with cardiac sympathetic overactivity in Type II diabetic patients. Diabetologia (2002) 0.82
Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity. J Endocrinol Invest (2002) 0.82
Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1985) 0.81
Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects. Horm Metab Res (2008) 0.81
Glycosylated haemoglobin and reticulocyte count in diabetes. Diabetologia (1982) 0.81
Bumetanide and glucose tolerance in man. Farmaco Prat (1980) 0.81
Prostaglandin E1 inhibits glucose-induced insulin secretion in man. Prostaglandins Med (1978) 0.81
Effects of leptin on lipid metabolism. Horm Metab Res (2008) 0.81
Opiate addict as diabetic patient? Diabetes Care (1988) 0.81
The squatting test. A useful tool to assess both parasympathetic and sympathetic involvement of the cardiovascular autonomic neuropathy in diabetes. Diabetes (1994) 0.81